JPRN-UMIN000029097招募中未知
Identification of HLA haplotype in tumor cells, after relapse following allogeneic hematopoietic stem cell transplantation from a haploidentical donor for hematological malignancy - Identification of HLA haplotype in relapsed tumor cells after haploidentical transplantation
Division of Hematology, Saitama Medical Center, Jichi Medical University0 个研究点目标入组 10 人开始时间: 2017年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Assessing Frequency of HLA-Genotype and Tumor Antigen Expression in Subjects with Relapsed/Refractory, Advanced-Stage Solid Tumors that may Qualify for Novel T Cell Receptor Based TherapiesNL-OMON53305T-knife GmbH400
已完成
不适用
Human Leukocyte Antigen Typing and Tumor Antigen Expression ProfilingRefractory CancerRecurrent CancerAdult Solid TumorNeoplasmsNCT03760952Immatics US, Inc.242
进行中（未招募）
不适用
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsSarcomaCervical CancerNCT05812027TScan Therapeutics, Inc.1,150
进行中（未招募）
不适用
Study of HLA-DR in Cell Cultures Isolated From Primary Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckCancerNCT06041464Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
招募中
不适用
Cell immunotherapy infusing HLA-haploidentical lymphocytes from a family member of non-HSCT donorRelapsed malignancies or refractory viral diseases after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000014236Osaka Women's and Children's Hospital15